interprofessional education |
28 |
partnership model |
28 |
social interaction anxiety |
28 |
dendrobium officinale |
13 |
polysaccharides |
13 |
sjogren's syndrome |
13 |
apoptosis |
12 |
covid-19 |
11 |
antigen-presentation |
10 |
aquaporin 5 |
10 |
cytokine and chemokine response |
10 |
mers-cov |
10 |
pathogenesis |
10 |
sars-cov |
10 |
sjögren's syndrome |
10 |
viral replication |
10 |
autoantibodies |
9 |
b-cell suppression |
8 |
mitochondrial dysfunction |
8 |
mouse model |
8 |
sars-cov-2 |
8 |
aqp5 |
7 |
autoimmune diseases |
6 |
a-253 |
5 |
animals |
5 |
apoptosis - drug effects |
5 |
chinese herbal medicine |
5 |
colorectal cancer |
5 |
confirmatory factor analysis |
5 |
cytokines |
5 |
diet therapy |
5 |
functional food |
5 |
m3 mucarinic acetylcholine receptor |
5 |
online interprofessional education |
5 |
t cells |
5 |
tnf-α |
5 |
validation |
5 |
amyloid beta-peptides - toxicity |
4 |
aquaporin 5 - metabolism |
4 |
b cells |
4 |
bcl-2-associated x protein - biosynthesis |
4 |
bcl-2-associated x protein - metabolism |
4 |
beta-amyloid |
4 |
caspase 3 - metabolism |
4 |
cell line |
4 |
cyclooctanes - pharmacology |
4 |
cytokine |
4 |
cytokines - biosynthesis |
4 |
dendrobium - chemistry |
4 |
diabetes |
4 |
dibenzocyclooctadiene lignans |
4 |
dioxoles |
4 |
disease models, animal |
4 |
female |
4 |
homocysteine |
4 |
homocysteine - toxicity |
4 |
humans |
4 |
inflammation - drug therapy - metabolism |
4 |
lignans - pharmacology |
4 |
lupus nephritis |
4 |
lymphocytes - drug effects |
4 |
m3 muscarinic receptor |
4 |
mechanism |
4 |
medicinal plants |
4 |
mice |
4 |
mice, inbred c57bl |
4 |
neuroprotective agents - pharmacology |
4 |
orchidaceae |
4 |
pc12 cells |
4 |
peptide fragments - toxicity |
4 |
phytochemical |
4 |
polycyclic compounds |
4 |
polysaccharide |
4 |
polysaccharides - therapeutic use |
4 |
primary sjögren’s syndrome |
4 |
proto-oncogene proteins c-bcl-2 - biosynthesis |
4 |
rats |
4 |
reactive oxygen species - metabolism |
4 |
saliva - secretion |
4 |
schisandra - chemistry |
4 |
schisandra chinensis (turcz.) baill. |
4 |
schisandrin b |
4 |
schisandrin c |
4 |
sjogren's syndrome - therapy |
4 |
submandibular gland - drug effects |
4 |
systemic lupus erythematosus |
4 |
traditional chinese medicine |
4 |
treatment outcome |
4 |
ace2 |
3 |
adoptive transfer |
3 |
aging |
3 |
alisol b 23-acetate |
3 |
anti-coronavirus |
3 |
anti-immunoinflammatory activity |
3 |
antibody production |
3 |
arkadia |
3 |
autoimmune disease |
3 |
b lympho |
3 |
breg cells |
3 |
cia |
3 |
cytecytokine production |
3 |
fibrosis |
3 |
humanized |
3 |
il-10 |
3 |
immunization |
3 |
in situ detection |
3 |
inflammation |
3 |
interleukin-17 |
3 |
latent tgf-β1 |
3 |
neutralization |
3 |
olfactory ecto-mesenchymal stem cells |
3 |
proteasome inhibition |
3 |
regulatory b cells |
3 |
sjögren's disease |
3 |
smad7 |
3 |
t follicular helper cells |
3 |
th17 cells |
3 |
tile scan |
3 |
treg cell |
3 |
autoimmunity |
2 |
b cell tolerance |
2 |
bladder cancer |
2 |
chinese medicine |
2 |
dendrobium - therapeutic use. |
2 |
effector t cell |
2 |
elisa |
2 |
elispot |
2 |
experimental autoimmune encephalomyelitis |
2 |
flow cytometry |
2 |
il-2r |
2 |
immunofluorescence |
2 |
inflammatory cytokines |
2 |
microenvironment |
2 |
multiple sclerosis |
2 |
mutations |
2 |
network pharmacology |
2 |
nf-κb |
2 |
nitration |
2 |
pcr |
2 |
peroxynitrite |
2 |
sjögren's syndrome. |
2 |
uc |
2 |
urothelial carcinoma |
2 |
biologics |
1 |
efficacy |
1 |
meta-analysis |
1 |
nano |
1 |
nanocarriers |
1 |
ocular drug delivery |
1 |
oral and maxillofacial surgery |
1 |
pathology |
1 |
polysaccharide-based nanomaterials |
1 |
safety |
1 |
salivary gland function |
1 |